Download BrochureLogin | Event OverviewWelcome to the Value Driven Pharma EventWhat happened since last year’s Value Driven Pharma event? Health Care Reform, that’s what. So, now what? The American Recovery and Reinvestment Act (ARRA) allocated $1.1 Billion for Comparative Effectiveness Research. Obtain the tools to deliver solid economic health data applicable to real-world needs and decisions faced by patients, clinicians and payers necessary to obtain formulary placement. The expansions outlined in ARRA will cover approximately 19 million uninsured beginning in 2014, increasing to 30 million by 2016. Respond to the shifting payer mix and optimize your formulary and reimbursement strategy to ensure to reap the benefits of increased prescription volumes. ARRA sets asides $19 billion to incent the adoption of Health Information Technology by doctors and hospitals. Register now for Value Driven Pharma to navigate the changing reimbursement paradigm to ensure your product’s value is undisputable. In addition, to helping you develop an organizational healthcare reform response strategy to comply with new regulations while containing costs, Value Driven Pharma provides the tactical and operational tools to:
2010 Featured Speakers
Stay Connected
Loading...
| ||||||||||||||||||||
| |||||||||||||||||||||